
|Articles|April 15, 2008
Lexiscan approved as new cardiac stress test agent
Regadenoson receives FDA approval as first A2A adenosine receptor agonist for myocardial perfusion imaging.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Dementia Increases Risk of COVID-19 Infection, Hospitalization for Older Patients
2
Pharmacists Provide Tailored Pneumococcal Vaccines to Patients With Down Syndrome
3
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder
4
Most Favored Nation, Direct-to-Consumer Strategies Reshape US Pharma Landscape, Challenging Traditional Care
5




















































































































































